Biofrontera Inc. (NASDAQ:BFRI) Short Interest Update

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 292,400 shares, a decline of 44.9% from the December 31st total of 530,600 shares. Based on an average daily trading volume, of 3,010,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.7% of the company’s stock are sold short.

Analysts Set New Price Targets

Separately, Benchmark reissued a “buy” rating and issued a $7.00 target price on shares of Biofrontera in a research report on Friday, November 15th.

Biofrontera Stock Up 1.0 %

NASDAQ:BFRI traded up $0.01 during mid-day trading on Thursday, hitting $1.06. 86,098 shares of the stock traded hands, compared to its average volume of 943,437. The stock has a market capitalization of $8.22 million, a price-to-earnings ratio of -0.47 and a beta of 0.27. Biofrontera has a 52 week low of $0.61 and a 52 week high of $2.43. The firm’s 50 day moving average is $1.05 and its two-hundred day moving average is $1.06.

About Biofrontera

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.